Ligand profile
GNG
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4780 — cytidine and deoxycytidylate deaminase zinc-binding region family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
GNG- PDB
4lcn- UniProt (similar protein)
Q82Y41- Target protein
- VK055_4780
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 139.3
- −1 ≤ LogP ≤ 5 -1.66
- MW ≤ 500 Da 267.2
- LogP ≤ 5 -1.66
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 139.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)NC(=NC2=O)Nc1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)NC(=NC2=O)N
InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1
YKBGVTZYEHREMT-KVQBGUIXSA-NYKBGVTZYEHREMT-KVQBGUIXSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00383
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand GNG →
- PDB RCSB structure 4lcn →
- UniProt UniProt Q82Y41 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “GNG”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4780.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).